menu ☰
menu ˟

[Comment] 17 and 23: prime numbers for ankylosing spondylitis?

23 Nov 2013

Treatment options for patients with ankylosing spondylitis have improved considerably over the past decade with the availability of tumour necrosis factor-α (TNF)-inhibitors. Traditional disease-modifying anti-rheumatic drugs such as methotrexate that are effective in rheumatoid arthritis have no proven benefit for spinal inflammatory arthritis, the hallmark of ankylosing spondylitis. TNF-inhibitors are often recommended when first-line therapy with non-steroidal anti-inflammatory drugs does not control disease activity, and are effective at reducing inflammation and symptoms of spinal pain and stiffness and improving function in most patients.

Date: 
23 November 2013

Click here to view the full article which appeared in The Lancet